Skip to content

Study on functional imaging and cognitive function of ultra-late onset schizophrenia

Study on functional imaging and cognitive function of ultra-late onset schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081075
Enrollment
Unknown
Registered
2024-02-21
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ultra-late onset schizophrenia

Interventions

Super late onset schizophrenia group:none
Early-onset schizophrenia elderly group:none

Sponsors

Beijing Anding Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Super late onset schizophrenia group Inclusion criteria (all 4 requirements must be met) : ? Provide written informed consent; (2) Meet the Diagnostic and Statistical Manual of Mental Disorders, fifth Edition, DSM-5 diagnostic criteria for schizophrenia; ? Age of first onset =60 years; ? All are right-handed (2) Early-onset schizophrenia elderly group Inclusion criteria (all 4 criteria must be met) : matched with the ultra-late-onset schizophrenia group in terms of age, sex, and education. Inclusion criteria (all 4 requirements must be met) : ? Provide written informed consent; ? Meet the DSM-5 diagnostic criteria for schizophrenia; Age =60 years old, first onset age <40 years old; ? All are right-handed.

Exclusion criteria

Exclusion criteria: (1) Super late onset schizophrenia group Exclusion criteria (meet 1 can be excluded) : ? have a history of epilepsy or coronary heart disease or other serious unstable physical diseases; Have participated in another interventional clinical study within the past 1 month; (3) Previous or current DSM-5 diagnosis of the following mental disorders: organic mental disorders, Alzheimer's disease, secondary dementia due to other causes, schizoaffective disorder, bipolar disorder, depressive disorder, delusional disorder, amorphous mental disorders; Patients with a history of substance abuse, including abuse of alcohol or active drugs, except nicotine, within the past 12 months; ? In the past 2 weeks, he has been taking drugs that affect cognitive function such as intelligent drugs; ? Patients with severe aphasia, visual and hearing impairment who cannot complete the assessment and those with MRI contraindications. (2) Early-onset schizophrenia elderly group Exclusion criteria (meet 1 can be excluded) : ? have a history of epilepsy or coronary heart disease or other serious unstable physical diseases; Have participated in another interventional clinical study within the past 1 month; (3) Previous or current DSM-5 diagnosis of the following mental disorders: organic mental disorders, Alzheimer's disease, secondary dementia due to other causes, schizoaffective disorder, bipolar disorder, depressive disorder, delusional disorder, amorphous mental disorders; Patients with a history of substance abuse, including abuse of alcohol and active drugs, except nicotine, within the past 12 months; ? In the past 2 weeks, he has been taking drugs that affect cognitive function such as intelligent drugs; ? Patients with severe aphasia, visual and hearing impairment who cannot complete the assessment and those with MRI contraindications.

Design outcomes

Primary

MeasureTime frame
The correlation between abnormal brain area functional connectivity strength, clinical characteristics, and cognitive function in super late onset schizophrenia;

Secondary

MeasureTime frame
Comparison of resting state fMRI brain functional connectivity differences between early-onset and ultra late onset schizophrenia;Clinical characteristics of early onset and super late onset schizophrenia;Assessment of cognitive function characteristics in super late onset schizophrenia;

Countries

China

Contacts

Public ContactLiu Man

Beijing Anding Hospital, Capital Medical University

473422818@qq.com+86 188 0119 9607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026